RARX
D.E. Shaw & Co’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-25,580
| Closed | -$1.23M | – | 2953 |
|
|
2020
Q1 | $1.23M | Buy |
+25,580
| New | +$1.23M | ﹤0.01% | 1765 |
|
|
2019
Q4 | – | Sell |
-157,655
| Closed | -$3.73M | – | 2890 |
|
|
2019
Q3 | $3.73M | Sell |
157,655
-259,215
| -62% | -$6.13M | ﹤0.01% | 1281 |
|
|
2019
Q2 | $12.5M | Sell |
416,870
-121,976
| -23% | -$3.67M | 0.02% | 770 |
|
|
2019
Q1 | $12.1M | Buy |
538,846
+291,604
| +118% | +$6.53M | 0.02% | 752 |
|
|
2018
Q4 | $4.5M | Buy |
247,242
+141,395
| +134% | +$2.57M | 0.01% | 1153 |
|
|
2018
Q3 | $1.92M | Buy |
105,847
+84,227
| +390% | +$1.52M | ﹤0.01% | 1544 |
|
|
2018
Q2 | $215K | Buy |
+21,620
| New | +$215K | ﹤0.01% | 2428 |
|
|
2017
Q4 | – | Sell |
-28,563
| Closed | -$417K | – | 2721 |
|
|
2017
Q3 | $417K | Buy |
28,563
+6,807
| +31% | +$99.4K | ﹤0.01% | 2126 |
|
|
2017
Q2 | $408K | Sell |
21,756
-16,088
| -43% | -$302K | ﹤0.01% | 2042 |
|
|
2017
Q1 | $806K | Sell |
37,844
-3,556
| -9% | -$75.7K | ﹤0.01% | 1804 |
|
|
2016
Q4 | $629K | Buy |
+41,400
| New | +$629K | ﹤0.01% | 1938 |
|